J Biomed Sci June 2023 PMID 37380989

Targeting cGAS/STING signaling-mediated myeloid immune cell dysfunction in TIME.

Vijay Kumar, Caitlin Bauer, John H Stewart

Mentions

4
Peak: 2 in Jun 2023
across 2 sources since Jun 2023

Extended reach

28,171
potential audience

Total likes

1

Video views

60

Mentions per month

Jun 2023 – Jun 2024

Where it's discussed

  • X / Twitter3 posts
  • YouTube1 videos

AI synopsis

What people are saying

The discussions demonstrate strong interest in tumor immunology, with phrases like 'for people interested in tumor immunology,' and express general support, as seen in comments appreciating the focus on cGAS-STING signaling. The tone is informative and slightly enthusiastic, suggesting an engaged audience that perceives the research as relevant but not revolutionary yet.

AgreementModerate agreement

Most discussions express support or appreciation for the research, indicating general agreement with its significance.

InterestHigh interest

The posts reveal high interest, especially among those invested in tumor immunology, with mentions of relevance to immune mechanisms.

EngagementModerate engagement

Comments include some thoughtful reactions and clarifications, showing a moderate level of engagement.

ImpactModerate impact

While enthusiasm is evident, the discussions are mostly exploratory rather than indicating a breakthrough impact.

Abstract in brief

  • The text explains how myeloid immune cells (MICs), which are early responders to pathogens and cellular changes, recognize altered cellular homeostasis, particularly through the cGAS-STING signaling pathway that detects cytosolic double-stranded DNA and triggers immune responses.
  • It discusses how changes in the tumor microenvironment (TME) and tumor immune microenvironment (TIME) can lead to dysfunction of MICs, specifically through alterations in cGAS-STING signaling, which then influence tumor-supportive immune changes.
  • The article suggests that targeting or modulating cGAS-STING signaling in MICs could serve as a promising approach for tumor immunotherapy, aiming to modify the TIME to improve anti-cancer immune responses.]

Top posts

Most liked on X and Bluesky
Christie Laura Grace
@_HeartofGrace_ · X

https://t.co/To2H0ynxh8 https://t.co/0RWhFqPLAJ https://t.co/To2H0ynxh8 https://t.co/H8RjcrZTej https://t.co/U7SWNBi3Ep

Jun 20, 2024 · 1 like · 27,073 followers View post →
Cancer epigenetics papers
@epicancerpapers · X

Targeting cGAS/STING signaling-mediated myeloid immune cell dysfunction in TIME https://t.co/CxPJJvTWtY

Jun 29, 2023 · 1,037 followers View post →

All mentions

Christie Laura Grace
@_HeartofGrace_ · X

https://t.co/To2H0ynxh8 https://t.co/0RWhFqPLAJ https://t.co/To2H0ynxh8 https://t.co/H8RjcrZTej https://t.co/U7SWNBi3Ep

Jun 20, 2024 · 1 like · 27,073 followers View post →
Cancer epigenetics papers
@epicancerpapers · X

Targeting cGAS/STING signaling-mediated myeloid immune cell dysfunction in TIME https://t.co/CxPJJvTWtY

Jun 29, 2023 · 1,037 followers View post →
Dr. Vijay Kumar
@DrVijay47993487 · X

For people interested in umor immunology. https://t.co/Q8n13SFjrb

Jun 28, 2023 · 1 followers View post →